How we secured a COVID ‐19 convalescent plasma procurement scheme in Japan

Author:

Terada Mari12,Kutsuna Satoshi1ORCID,Togano Tomiteru34,Saito Sho134,Kinoshita Noriko134,Shimanishi Yumiko1,Suzuki Tetsuya134,Miyazato Yusuke1,Inada Makoto1,Nakamoto Takahito1,Nomoto Hidetoshi134,Ide Satoshi134,Sato Mitsuhiro1,Maeda Kenji5,Matsunaga Akihiro6,Satake Masahiro7ORCID,Matsubayashi Keiji7,Tsuno Hirokazu8,Kojima Makiko8,Kuramistu Madoka9,Tezuka Kenta9,Ikebe Emi9,Okuma Kazu9,Hamaguchi Isao9,Shiratori Katsuyuki10,Sato Motohiko11,Kawakami Yuiko11,Inaba Kumi11,Igarashi Saori12,Yamauchi Reina12,Matsumura Mina12,Ishimaru Keiko12,Zhang Bijuan12,Kuge Chika12,Ishihara Maiko12,Gouda Miho12,Tanaka Keiko12,Ishizaka Yukihito13,Ohmagari Norio134

Affiliation:

1. Disease Control and Prevention Center National Center for Global Health and Medicine Tokyo Japan

2. Center for Clinical Sciences National Center for Global Health and Medicine Tokyo Japan

3. Emerging and Reemerging Infectious Diseases Graduate School of Medicine, Tohoku University Sendai Japan

4. Department of Hematology National Center for Global Health and Medicine Tokyo Japan

5. Department of Refractory Viral Infections, Research Institute National Center for Global Health and Medicine Tokyo Japan

6. Department of Intractable Diseases Research Institute, National Center for Global Health and Medicine Tokyo Japan

7. Japanese Red Cross Central Blood Institute Tokyo Japan

8. Japanese Red Cross Kanto‐Koshin‐etsu Block Blood Center Tokyo Japan

9. Department of Safety Research on Blood and Biological Products National Institute of Infectious Diseases Tokyo Japan

10. Clinical Laboratory Department National Center for Global Health and Medicine Tokyo Japan

11. Department of Clinical Engineering National Center for Global Health and Medicine Tokyo Japan

12. Nursing Department National Center for Global Health and Medicine Tokyo Japan

13. Research Institute National Medical Center for Global Health and Medicine Tokyo Japan

Funder

Ministry of Health, Labour and Welfare

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Reference17 articles.

1. World Health Organization.Coronavirus disease (COVID‐19) pandemic. 2020.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed 10 Aug 2020.

2. World Health Organization.Therapeutics and COVID‐19: living guideline. 2021.https://www.who.int/publications/i/item/therapeutics-and-covid-19-living-guideline. Accessed 20 Mar 2021.

3. Dexamethasone in Hospitalized Patients with Covid-19

4. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

5. Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3